$RYES
Rise Gold Corp.

2021 Q4 Form 10-K Financial Statement

#000106299321009984 Filed on October 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $427.6K $539.6K $2.389M
YoY Change -58.88% 81.89% 49.5%
% of Gross Profit
Research & Development $54.52K $186.1K $782.3K
YoY Change -71.21% -70.32% -52.21%
% of Gross Profit
Depreciation & Amortization $6.230K $6.570K $25.58K
YoY Change 0.32% 15.26% 11.27%
% of Gross Profit
Operating Expenses $511.1K $754.7K $3.286M
YoY Change -59.38% -20.8% -1.59%
Operating Profit
YoY Change
Interest Expense $298.1K $178.6K $119.5K
YoY Change 29.58% -119.49% 18.32%
% of Operating Profit
Other Income/Expense, Net $700.00 $610.00 $4.890K
YoY Change -74.55% -94.44% -97.4%
Pretax Income -$212.3K -$575.5K -$1.604M
YoY Change -79.3% -69.03% -70.69%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$212.3K -$575.5K -$1.604M
YoY Change -79.3% -69.03% -70.69%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.06
Diluted Earnings Per Share -$7.930K -$21.19K -$60.02K
COMMON SHARES
Basic Shares Outstanding 26.77M shares 26.72M shares
Diluted Shares Outstanding 26.77M shares 26.72M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $397.1K $773.3K $773.3K
YoY Change -86.09% -77.11% -77.11%
Cash & Equivalents $397.1K $773.3K
Short-Term Investments
Other Short-Term Assets $319.1K $339.0K $339.0K
YoY Change -7.95% -6.77% -6.77%
Inventory
Prepaid Expenses $319.1K $339.0K
Receivables $47.25K $44.11K $44.11K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $763.4K $1.156M $1.156M
YoY Change -76.35% -69.26% -69.26%
LONG-TERM ASSETS
Property, Plant & Equipment $569.6K $575.8K $4.725M
YoY Change -87.99% -4.25% -0.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.719M $4.725M $4.725M
YoY Change -0.54% -0.54% -0.54%
TOTAL ASSETS
Total Short-Term Assets $763.4K $1.156M $1.156M
Total Long-Term Assets $4.719M $4.725M $4.725M
Total Assets $5.482M $5.881M $5.881M
YoY Change -31.24% -30.91% -30.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $269.0K $165.9K $165.9K
YoY Change -23.05% -60.05% -60.05%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $289.0K $199.9K $199.9K
YoY Change -21.83% -59.6% -59.6%
LONG-TERM LIABILITIES
Long-Term Debt $1.038M $976.6K $976.6K
YoY Change 29.69% 31.59% 31.59%
Other Long-Term Liabilities $104.7K $441.8K $441.8K
YoY Change -94.66% -80.08% -80.08%
Total Long-Term Liabilities $1.142M $1.418M $1.418M
YoY Change -58.63% -52.09% -52.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $289.0K $199.9K $199.9K
Total Long-Term Liabilities $1.142M $1.418M $1.418M
Total Liabilities $1.431M $1.618M $1.618M
YoY Change -54.29% -53.16% -53.16%
SHAREHOLDERS EQUITY
Retained Earnings -$19.54M
YoY Change 8.94%
Common Stock $26.77K $26.77K
YoY Change 1.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.051M $4.263M $4.263M
YoY Change
Total Liabilities & Shareholders Equity $5.482M $5.881M $5.881M
YoY Change -31.24% -30.91% -30.91%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income -$212.3K -$575.5K -$1.604M
YoY Change -79.3% -69.03% -70.69%
Depreciation, Depletion And Amortization $6.230K $6.570K $25.58K
YoY Change 0.32% 15.26% 11.27%
Cash From Operating Activities -$376.2K -$761.7K -$2.854M
YoY Change -51.28% -11.89% -6.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $248.2K
YoY Change -100.0% -100.0% -96.02%
NET CHANGE
Cash From Operating Activities -376.2K -761.7K -$2.854M
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000 $248.2K
Net Change In Cash -376.2K -761.7K -$2.606M
YoY Change -28.2% -132.37% -182.33%
FREE CASH FLOW
Cash From Operating Activities -$376.2K -$761.7K -$2.854M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26770298 shares
CY2020 us-gaap Accretion Expense
AccretionExpense
104518 USD
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
80000 USD
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
84167 USD
CY2021 ryes Filing And Regulatory Expense
FilingAndRegulatoryExpense
55601 USD
CY2020 ryes Filing And Regulatory Expense
FilingAndRegulatoryExpense
55464 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
20297 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-21451 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
399940 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
440616 USD
CY2021 ryes Geological Mineral And Prospect Costs
GeologicalMineralAndProspectCosts
782261 USD
CY2020 ryes Geological Mineral And Prospect Costs
GeologicalMineralAndProspectCosts
1636791 USD
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
119523 USD
CY2020 us-gaap Interest Expense Other
InterestExpenseOther
101014 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
517092 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
244764 USD
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
175567 USD
CY2020 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
176652 USD
CY2021 us-gaap Salaries And Wages
SalariesAndWages
145545 USD
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
560792 USD
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26770298 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26770298 shares
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
45469 USD
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Vancouver
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021Q1 dei Entity Public Float
EntityPublicFloat
11587079 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214158 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
363646 USD
CY2021Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
4149053 USD
CY2020Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
4149053 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
601360 USD
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
79479 USD
CY2020Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
742157 USD
CY2020Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2218107 USD
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26436965 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26436965 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
26770 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
26437 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23076139 USD
CY2021 us-gaap Accretion Expense
AccretionExpense
114907 USD
CY2021 us-gaap Legal Fees
LegalFees
454176 USD
CY2020 us-gaap Legal Fees
LegalFees
89139 USD
CY2020 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
357271 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1776341 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2218107 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
19924 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8300 USD
CY2021 us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
0 USD
CY2020 us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
-101339 USD
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
250000 USD
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5499131 USD
CY2021 us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
1000000 USD
CY2021 ryes Loan Financing Expense
LoanFinancingExpense
0 USD
CY2020 ryes Loan Financing Expense
LoanFinancingExpense
-15000 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1802 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
49124 USD
CY2021 ryes Repayment Of Equipment Loan
RepaymentOfEquipmentLoan
0 USD
CY2020 ryes Repayment Of Equipment Loan
RepaymentOfEquipmentLoan
-203650 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2605547 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3164668 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4254532 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5057893 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4263005 USD
CY2020 ryes Effect Of Change In Functional Currency
EffectOfChangeInFunctionalCurrency
22676 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5450007 USD
CY2020 ryes Warrants Issued For Financing Expense
WarrantsIssuedForFinancingExpense
444942 USD
CY2020 us-gaap Salaries And Wages
SalariesAndWages
149724 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-3385107 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-3461571 USD
CY2021 us-gaap Other Operating Income
OtherOperatingIncome
4888 USD
CY2020 us-gaap Other Operating Income
OtherOperatingIncome
188219 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1603878 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5471535 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.25
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26721896 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21835235 shares
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1.</strong><span style="width:28.5pt;text-indent:0pt;display:inline-block">&#160;</span><strong>NATURE AND CONTINUANCE OF OPERATIONS</strong></span></span></p> <div> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rise Gold Corp. (the "Company") was originally incorporated as Atlantic Resources Inc. in the State of Nevada on February 9, 2007 and is in the exploration stage. On April 11, 2012, the Company merged its wholly-owned subsidiary, Patriot Minefinders Inc., a Nevada corporation, in and to the Company to effect a name change to Patriot Minefinders Inc. On January 14, 2015, the Company completed a name change to Rise Resources Inc. in the same manner. On March 29, 2017, the Company changed its name to Rise Gold Corp. These mergers were carried out solely for the purpose of effecting these changes of names.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 18, 2020, the Company increased its authorized capital from 40,000,000 shares to 400,000,000 shares.&#160;</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 29, 2016, the Company completed an initial public offering in Canada and began trading on the Canadian Securities Exchange ("CSE") on February 1, 2016.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is in the early stages of exploration and as is common with any exploration company, it raises financing for its acquisition activities. The accompanying consolidated financial statements have been prepared on the going concern basis, which presumes that the Company will continue operations for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. The Company has incurred a loss of $1,603,878 for the year ended July 31, 2021 and has accumulated a deficit of $19,544,477. The ability of the Company to continue as a going concern is dependent on the Company's ability to maintain continued support from its shareholders and creditors and to raise additional capital and implement its business plan. There is no assurance that the Company will be able to obtain adequate financing in the future or that such financing will be on terms advantageous to the Company. However, management believes that the Company has sufficient working capital to meet its projected minimum financial obligations for the next fiscal year. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2020, the novel coronavirus outbreak ("COVID-19") was declared a pandemic by the World Health Organization. The situation is dynamic and the ultimate duration and magnitude of the impact on the economy and the Company's business are not known at this time. These impacts could include an impact on the Company's ability to obtain debt and equity financing to fund ongoing exploration activities as well as its ability to explore and conduct business. These consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At July 31, 2021, the Company had working capital of $956,524 (2020 - working capital of $3,267,744).</span></span></p> </div> </div> </div>
CY2021 us-gaap Basis Of Accounting
BasisOfAccounting
<div> <p style="margin-left:36pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2.</strong><span style="width:28.5pt;text-indent:0pt;display:inline-block"> </span><strong>BASIS OF PREPARATION</strong></span></span></p> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Generally accepted accounting principles</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America ("US GAAP") for financial information with the instructions to Form 10-K and Regulation S-K.</span></span></p> </div> </div> <div> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Basis of Consolidation</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Rise Grass Valley Inc. All significant intercompany accounts and transactions have been eliminated on consolidation.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Subsidiaries</i></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries are all entities over which the Company has exposure to variable returns from its involvement and has the ability to use power over the investee to affect its returns. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company until the date on which control ceases.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounts of subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies. Intercompany transactions, balances and unrealized gains or losses on transactions are eliminated upon consolidation.</span></span></p> </div> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Use of Estimates</strong></span></span></p> <p style="margin-left:35.45pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant areas requiring the use of estimates include the carrying value and recoverability of mineral properties and the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. Actual results could differ from those estimates&#160;and would impact future results of operations and cash flows.</span></span></p> </div> </div>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Use of Estimates</strong></span></span></p> <p style="margin-left:35.45pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant areas requiring the use of estimates include the carrying value and recoverability of mineral properties and the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. Actual results could differ from those estimates&#160;and would impact future results of operations and cash flows.</span></span></p> </div>
CY2021 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
straight-line basis
CY2021 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P15Y
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Concentration of credit risk</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial instrument which potentially subjects the Company to concentration of credit risk is cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. As of July 31, 2021, and 2020, the Company has not exceeded the federally insured limit. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts.</span></span></p> </div>
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
79479 USD
CY2018Q3 ryes Equipment Loan
EquipmentLoan
495481 USD
CY2019Q3 ryes Equipment Loan
EquipmentLoan
223574 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-429000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1148000 USD
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1094000 USD
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-158000 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
150000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
253000 USD
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-7000 USD
CY2021 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
-815000 USD
CY2020 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
1060000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 ryes Deferred Tax Assets Mineral Property Interest
DeferredTaxAssetsMineralPropertyInterest
27000 USD
CY2020Q3 ryes Deferred Tax Assets Mineral Property Interest
DeferredTaxAssetsMineralPropertyInterest
1381000 USD
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1091000 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2228000 USD
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1118000 USD
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3609000 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1118000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3609000 USD
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4085000 USD
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7650000 USD

Files In Submission

Name View Source Status
0001062993-21-009984-index-headers.html Edgar Link pending
0001062993-21-009984-index.html Edgar Link pending
0001062993-21-009984.txt Edgar Link pending
0001062993-21-009984-xbrl.zip Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kx001.jpg Edgar Link pending
form10kx002.jpg Edgar Link pending
form10kx003.jpg Edgar Link pending
form10kx004.jpg Edgar Link pending
form10kx005.jpg Edgar Link pending
form10kx006.jpg Edgar Link pending
form10kx007.jpg Edgar Link pending
form10kx008.jpg Edgar Link pending
form10kxu001.jpg Edgar Link pending
form10kxu002.jpg Edgar Link pending
form10kxu003.jpg Edgar Link pending
form10kxu004.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ryes-20210731.xml Edgar Link completed
ryes-20210731.xsd Edgar Link pending
ryes-20210731_cal.xml Edgar Link unprocessable
ryes-20210731_def.xml Edgar Link unprocessable
ryes-20210731_lab.xml Edgar Link unprocessable
ryes-20210731_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending